MDMA-assisted psychotherapy may help soldiers with PTSD reduce symptoms, rebuild lives, study finds

A groundbreaking study reveals that MDMA-assisted psychotherapy significantly reduced post-traumatic stress disorder (PTSD) symptoms in soldiers, with approximately 80% of participants no longer meeting the diagnostic criteria for the disorder by the study's end.

“

Approximately 15% of combat soldiers exposed to severe battlefield trauma may develop chronic PTSD.

The research, conducted at Clalit Health Services' HaEmeek Medical Center in Northern Israel, addresses a growing need for effective PTSD treatments. Since the events of October 7 and the subsequent war, PTSD diagnoses in Israel have increased by roughly 70%. Clinical psychologist Ronen Sidi noted that an estimated 15% of combat soldiers exposed to severe battlefield trauma may develop chronic PTSD.

Sidi, a former special forces soldier, highlighted the resilience of individuals with PTSD, who often struggle to seek help or openly discuss their experiences of fear, guilt, or helplessness. Dr. Alon Reshef, Director of Psychiatry at Clalit-HaEmek Medical Center and the study's principal investigator, stressed the profound impact of PTSD on soldiers, their families, and society. He emphasized that early intervention is key, with recovery chances significantly higher when treatment begins within the first year after the traumatic event, though meaningful breakthroughs are possible even in chronic cases.

“

The number of people coping with post-traumatic stress since October 7 is enormous. Beyond the personal suffering experienced by these soldiers, PTSD has a profound impact on their families and on society as a whole.

Both Sidi and Reshef underscored that MDMA functions as a therapeutic tool within a comprehensive treatment program, not as a cure itself. The full treatment involves 13 intensive psychotherapy sessions, including three monitored sessions where MDMA is administered under strict medical supervision. During these sessions, patients are accompanied by two experienced therapists trained in trauma treatment. The MDMA is believed to enable patients to engage with traumatic memories while maintaining emotional regulation and a sense of psychological safety, allowing them to process deeply challenging emotions like shame, guilt, and helplessness more effectively.

“

When patients begin treatment within the first month to one year after the traumatic event, their chances of recovery are significantly better. As more years pass, treatment becomes increasingly complex. Even so, meaningful breakthroughs are possible, even in chronic cases.